Zdrowie i gospodarka · 31.08.1998
Global Harmonization Task Force: Draft Documents on Adverse Event and Vigilance Reporting of Medical Device Events; Availability
The Food and Drug Administration (FDA) is announcing the availability of five draft documents entitled ``Comparison of Device Adverse Report Systems'' (SG2-N6), ``Guidance on How to Handle Information Concerning Vigilance Reporting Related to Medical Devices'' (SG2-N8), ``Global Medical Devices Vigilance Report (Form and Instructions)'' (SG2-N9), ``Pre' cis'' (Vigilance and Postmarket Surveillance) (SG2-N12), and ``Adverse Event Reporting Guidelines for Manufacturers'' (SG-N21). These documents have been prepared by members of the Global Harmonization Task Force (GHTF), study group 2 on Medical Devices Vigilance/Postmarket Surveillance Reporting Systems. The documents are intended to provide information only and represent a harmonized group of proposals. Elements of the approach set forth in these documents may not be consistent with current U.S. regulatory requirements. FDA is requesting comments on these documents.